Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190427043390N1Phase 2Completed
Phase 2, single-blind trial of tranexamic acid in primary osteoarthritis (OA) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Mean amount of blood lost during and after surgery, Postoperative blood volume and 1 more. Started Sep 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190427043390N1.